Karla Lehle Selected Research

Karla Lehle Research Topics

12	Thrombosis (Thrombus) 01/2024 - 07/2013
6	Hemolysis 11/2023 - 11/2009
5	Inflammation (Inflammations) 01/2024 - 05/2013
4	Critical Illness (Critically Ill) 01/2021 - 05/2014
3	Thrombocytopenia (Thrombopenia) 01/2024 - 08/2011
3	Bronchiolitis Obliterans 07/2019 - 07/2012
3	Hemorrhage 04/2016 - 04/2011
3	Type 2 Diabetes Mellitus (MODY) 11/2011 - 05/2007
2	Shock 01/2022 - 01/2017
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2018
2	Reperfusion Injury 10/2018 - 11/2010
2	Body Weight (Weight, Body) 10/2018 - 07/2012
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2016 - 11/2008
2	Wounds and Injuries (Trauma) 01/2015 - 11/2009
2	Diabetes Mellitus 11/2011 - 10/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2010 - 10/2007
1	COVID-19 08/2022
1	Vascular System Injuries 01/2022
1	Hyperplasia 01/2022
1	Foreign Bodies (Foreign Body) 11/2019
1	Fibrosis (Cirrhosis) 07/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2018
1	Arteriosclerosis 10/2018
1	Hypercholesterolemia 10/2018
1	Atherosclerosis 10/2018
1	Spinal Cord Ischemia 10/2018
1	Pathologic Constriction (Stenosis) 08/2017
1	Acidosis 01/2017
1	Cardiogenic Shock 01/2017
1	Residual Neoplasm 03/2015
1	Multiple Trauma (Multiple Injuries) 01/2015
1	Airway Remodeling 05/2013
1	Disease Susceptibility (Diathesis) 04/2011
1	Infections 04/2011
1	Bacteremia 04/2011
1	Cicatrix (Scar) 11/2004
1	Aortic Aneurysm (Aneurysm, Aortic) 05/2004
1	Bicuspid Aortic Valve Disease 05/2004

3	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 08/2011
3	Fibrinogen (Factor I)FDA Link 01/2021 - 04/2011
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 05/2014
3	Indicators and Reagents (Reagents)IBA 11/2019 - 01/2015
2	AnticoagulantsIBA 01/2022 - 08/2011
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Cell-Free Nucleic AcidsIBA 11/2023
1	Antithrombin IIIIBA 11/2023
1	argatroban (MPQA)FDA Link 01/2022
1	von Willebrand FactorIBA 11/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2019
1	Imatinib Mesylate (Gleevec)FDA Link 07/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2019
1	vatalanib (PTK787)IBA 07/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2019
1	sodium sulfideIBA 10/2018
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2018
1	Sodium Chloride FDA LinkGeneric 10/2018
1	Sulfides (Thioethers)IBA 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 03/2015
1	Hemostatics (Antihemorrhagics)IBA 11/2014
1	Everolimus FDA Link 05/2013
1	HirudinsIBA 08/2011
1	Anesthetics (Anesthetic Agents)IBA 11/2010
1	E-SelectinIBA 10/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2007
1	Interleukin-6 (Interleukin 6)IBA 10/2007
1	Collagen Type III (Type III Collagen)IBA 11/2004
1	CollagenIBA 11/2004
1	perforin-granzyme BIBA 05/2004
1	Proteins (Proteins, Gene)FDA Link 05/2004
1	DNA (Deoxyribonucleic Acid)IBA 05/2004

14	Extracorporeal Membrane Oxygenation 01/2024 - 11/2008
9	Therapeutics 01/2024 - 03/2015
8	Oxygenators 01/2023 - 07/2013
7	Membrane Oxygenators (Membrane Oxygenator) 01/2023 - 11/2008
3	Extracorporeal Circulation 11/2011 - 10/2007
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2011 - 05/2007
2	Lung Transplantation 05/2013 - 07/2012
1	Length of Stay 08/2022
1	Stents 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Sutures (Suture) 08/2017
1	Cardiopulmonary Resuscitation (CPR) 01/2017
1	Drug Therapy (Chemotherapy) 03/2015
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2015
1	Erythrocyte Transfusion 01/2015
1	Cannula 01/2015
1	Transplantation 07/2012
1	Induced Hypothermia 02/2010
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2009